The Indo US Bridging RARE Summit
The Indo US Bridging RARE Summit, scheduled for Nov 16-18 2024 is based on the theme “Combating Rare Diseases by Fostering Cross-Border Collaborations, Data Sharing, and Clinical Trials” and promises to provide a unique program that will focus on cross-border collaborations and new perspectives from a broad spectrum of stakeholders of rare diseases.This prestigious event […]
Evolent to acquire AI-powered platform, Machinify Auth App, from Machinify
Evolent Health, Inc. (“Evolent” or “the Company”), a company focused on achieving better health outcomes for people with complex conditions, today announced it has entered into an agreement to acquire certain assets of Machinify and the exclusive, perpetual and royalty-free license of Machinify Auth, a proven software platform that leverages the latest advances in artificial intelligence […]
Winona welcomes Dr. Cathleen Brown Director of Winona
Winona, the leading menopause telehealth company dedicated to transforming women’s health, announced the appointment of Dr. Cathleen Brown as its Medical Director. In her new role, Dr. Brown will serve as the spokesperson for the company and contribute regularly to the Winona Medical Journal, enriching the platform with her expertise in women’s health and menopause care. With […]
Cognivia announces strategic EUR 15.5Mln funding
Cognivia, an innovative AI company dedicated to reshaping pharmaceutical and biotech clinical research through cutting edge AI-ML algorithms, announced a significant investment milestone. Vesalius Biocapital IV, SFPIM (Société Fédérale de Participations et d’Investissement) and WE (Wallonie Entreprendre) have committed strategic investments to drive Cognivia’s mission to “quantify the power of the mind” to optimize and […]
AIROS Medical appoints Darren Behuniak as COO
AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous complications, yesterday announced it has named Darren M. Behuniak as its Chief Operating Officer. Behuniak is a co-founder of AIROS and has been serving as vice president of operations and marketing since the company’s founding in […]
Regence BlueCross BlueShield of Utah names Mike Woodruff as Executive Medical Director
Regence BlueCross BlueShield of Utah welcomes Dr. Mike Woodruff as its new executive medical director. In this executive leadership role, he will drive clinical strategies focused on improving health care access, affordability, quality and member experience. Woodruff will oversee initiatives to promote provider partnerships, engage key employers in enhancing workforce well-being to manage health care costs, […]
STEMCELL Technologies acquires Propagenix Inc.
STEMCELL Technologies, Canada’s largest biotechnology company, announced the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. “The acquisition of Propagenix is an important step in STEMCELL’s growth journey and an achievement for Canada’s biotechnology industry,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Propagenix’s technology […]
ClinChoice Expands its Footprint to Southeast Asia by acquiring CSI
ClinChoice, a leading global Contract Research Organization (CRO), announced expanding its global footprint with the acquisition of CSI Medical Research (CSI). CSI is a regional clinical CRO with professional staff and partners located across Asia (SEA), Australia and New Zealand (ANZ), to provide innovative and cost-effective clinical solutions. Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service […]
Molecular Partners and Orano Med collaborate to develop novel Radio-DARPin therapeutics
Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a pioneer in targeted alpha therapy, have announced a collaboration to develop novel Radio-DARPin therapeutics (RDTs) that use Orano Med’s 212Pb radioisotope as a payload to selectively kill cancer cells. Both companies will leverage their […]
Veracyte appoints Phillip G. Febbo for two designations
Veracyte, Inc. yeterday announced that Phillip G. Febbo, M.D., will join the company on October 2 as chief scientific officer and chief medical officer. Dr. Febbo, a distinguished industry and academic leader, will lead Veracyte’s global team of research and development, medical affairs, clinical affairs, quality, regulatory affairs, and lab director professionals to help advance […]
